Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 12, 2002, Pages 1655-1665

  De Angelis, Noeleen ^a   Fiordaliso, Fabio ^a   Latini, Roberto ^a   Calvillo, Laura ^a   Funicello, Marcella ^a   Gobbi, Marco ^a   Mennini, Tiziana ^a   Masson, Serge ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Aldosterone; Angiotensin II; Apoptosis; AT1 receptor; Isolated cells; Myocytes; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CASPASE 3; RENIN; SPIRONOLACTONE; VALSARTAN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART VENTRICLE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL NUCLEUS; CELLS, CULTURED; DOWN-REGULATION; HEART VENTRICLES; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; TETRAZOLES; VALINE;

EID: 0036901481     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2115     Document Type: Article

References (32)

1. Haunstetter A, Izumo S. Apoptosis. Basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82: 1111-1129.
2. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W. Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29: 859-870.
3. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998; 101: 1326-1342.
4. Pierzchalski P, Reiss K, Cheng W, Cirielli C, Kajstura J, Nitahara JA, Rizk M, Capogrossi MC, Anversa P. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res 1997; 234: 57-65.
5. Leri A, Fiordaliso F, Setoguchi M, Limana F, Bishopric N, Kajstura J, Webster K, Anversa P. Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis. Am J Pathol 2000; 157: 843-857.
6. Ravassa S, Fortuno MA, Gonzalez A, Lopez B, Zalba G, Fortuno A, Diez J. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats. Hypertension 2000; 36: 1065-1071.
7. Sugino H, Ozono R, Kurisu S, Matsuura H, Ishida M, Oshima T, Kambe M, Teranishi Y, Masaki H, Matsubara H. Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice. Hypertension 2001; 37: 1394-1398.
8. 1 receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. Am J Physiol 2002; 282: H1635-H1641.
9. 2 receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death. Am J Pathol 2000; 156: 1663-1672.
10. Heymes C, Silvestre JS. Llorens-Cortes C, Chevalier B, Marotte F, Levy BI, Swynghedauw B, Samuel JL. Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes. Endocrinol 1998; 139: 2579-2587.
11. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000; 45: 528-537.
12. Sugino H, Ozono R, Kurisu S, Matsuura H, Ishida M, Oshima T, Kambe M, Teranishi Y, Masaki H, Matsubara H. Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice. Hypertension 2001; 37: 1394-1398.
13. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999; 33: 340-346.
14. Sun Y, Weber KT. Angiotensin II and aldosterone receptor binding in rat heart and kidney: Response to chronic angiotensin II or aldosterone administration. J Lab Clin Med 1993; 122: 404-411.
15. Puri PL, Avantaggiati ML, Burgio ML, Chirillo P, Collepardo D, Natoli G, Balsano C, Levrero M. Reactive oxygen intermediates mediate angiotensin II-induced c-jun/c-fos heterodimeric DNA binding activity and proliferative responses in myogenic cells. J Biol Chem 1995; 270: 22129-22134.
16. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Oxidative-stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001; 89: 279-286.
17. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS. Limana F, Nadal-Ginard B, Leri A, Anversa P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001; 50: 1414-1424.
18. Ichiki T, Takeda K, Tokunou T, Funakoshi Y, Ito K, Iino N, Takeshita A. Reactive oxygen species-mediated homologous downregulation of angiotensin II type 1 receptor mRNA by angiotensin II. Hypertension 2001; 37: 535-540.
19. Rocha R, Stier Jr CT, Kifor I, Ochoa-Maya MR, R nnke HG, Williams GH, Adler GK. Aldosterone: A mediator of myocardial necrosis and renal arteriopathy. Endocrinol 2000; 141: 3871-3878.
20. Weber KT, Sun Y, Campbell SE, Slight SH, Ganjam VK, Griffing GT, Swinfard RW, Diaz-Arias AA. Chronic mineralocorticoid excess and cardiovascular remodeling. Steroids 1995; 60: 125-132.
21. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. New Engl J Med 1999; 341: 709-717.
22. Dorrance AM, Osborn HL, Grekin R, Webb RC. Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke prone rats. Am J Physiol 2001; 281: R944-R950.
23. McCullers DL, Herman JP. Mineralocorticoid receptors regulate bcl-2 and p53 mRNA expression in hippocampus. Neuroreport 1998; 9: 3085-3089.
24. 1 receptor subtype as a cardiac target of aldosterone. Role in aldosterone-salt-induced fibrosis. Hypertension 1999; 33: 981-986.
25. Schaper J, Elsässer A, Kostin S. The role of cell death in heart failure. Circ Res 1999; 85: 867-869.
26. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Redd JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996, 74: 86-107.
27. Goussev A, Sharov VG, Shimoyama H, Tanimura M. Lesch M, Goldstein S, Sabbah HN. Effect of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 1998; 275: H626-H631.
28. Yu G, Liang X, Xie X, Su M, Zhao S. Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats. Int J Cardiol 2001; 81: 123-129.
29. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998; 273: 4883-4891.
30. Silvestre JS, Heymes C, Oubénaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999; 99: 2694-2701.
31. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y, Nakao K. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103: 72-77.
32. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Horie H, Sugimoto Y, Kinoshita M. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 2000; 36: 838-844.